MONDAY, May 24, 2021 (HealthDay News) — Doctors for the first time have used a form of gene therapy to restore partial vision in a blind person, according to findings announced Monday. The research team genetically altered retinal ganglion cells to become light-sensitive in a man whose vision was destroyed by retinitis pigmentosa, a genetic … Read more
In 2019 the NHS agreed to fund the treatment, Luxturna, the first in a new generation of gene therapies for conditions causing blindness. It costs about £600,000 per patient to treat both eyes, though the NHS has agreed a confidential discount with the makers Novartis. Source link
Meindert Boysen, deputy chief executive and director of the Centre for Health Technology Evaluation at Nice, said: “Spinal Muscular Atrophy is a very serious, debilitating and distressing condition that has very significant effects on every aspect of life of those with SMA, and their families and carers. Source link
Sept. 25, 2020 — Since the beginning of the COVID-19 pandemic, scientists have struggled to find out why some people who get COVID-19 develop severe disease, and others are infected but don’t notice symptoms. Now, new research from the National Institutes of Health and other institutions suggests that some people have antibodies that are … Read more
SINGAPORE—Government researchers wheeled containers teeming with penned-up mosquitoes through a dense apartment complex at the city state’s northern tip. Over the next couple of hours, they periodically lifted the lids, allowing swarms of the insects to fly loose. Releasing mosquitoes into the corridors of apartment complexes might seem like an unusual strategy for a city … Read more